CNX And Adalvo Claim A UK First With Nitrofurantoin
Firms Announce First-To-Market Launch Of ‘Challenging’ Prolonged-Release Product
Adalvo and CNX Therapeutics have together claimed the first UK launch of a nitrofurantoin generic, introducing their prolonged-release formulation and revealing plans for further European launches.
